Ashish A Kulkarni (Ashish Kulkarni)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Advanced materials (Deerfield Beach, Fla.)

ACS applied materials & interfaces

Science advances

University of Massachusetts Amherst

University of Cincinnati (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Massachusetts Amherst

United States

Assistant Professor :: Chemical Engineering

Harvard Medical School/Brigham and Women's Hopsital

United States

Instructor :: Medicine

Education History

University of Cincinnati

United States

PHD :: Chemistry

Publications

Dipika Nandi, James Forster, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Dipika Nandi, James Forster, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Dipika Nandi, James Forster, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Maharshi Debnath, James Forster, Anujan Ramesh, Ashish A Kulkarni
Protein Corona Formation on Lipid Nanoparticles Negatively Affects the NLRP3 Inflammasome Activation. Bioconjugate chemistry (2023)
Dipika Nandi, James Forster, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Dipika Nandi, James Forster, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Dipika Nandi, James Forster, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Anujan Ramesh, Nilesh Deshpande, Vaishali Malik, Anh Nguyen, Mehak Malhotra, Maharshi Debnath, Anthony Brouillard, Ashish A Kulkarni
Activatable Nanoreporters for Real-Time Tracking of Macrophage Phenotypic States Associated with Disease Progression. Small (Weinheim an der Bergstrasse, Germany) (2023)
Dipika Nandi, James Forster, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 10 (6) (2023)
Dipika Nandi, James Forster Iii, Anujan Ramesh, Anh Nguyen, Hariharan Bharadwaj, Ashish A Kulkarni
Caspase-1 Responsive Nanoreporter for In Vivo Monitoring of Inflammasome Immunotherapy. ACS applied materials & interfaces (2023)
Anh Nguyen, Sahana Kumar, Ashish A Kulkarni
Nanotheranostic Strategies for Cancer Immunotherapy. Small methods (2022)
Anujan Ramesh, Vaishali Malik, Anthony Brouillard, Ashish A Kulkarni
Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth. Journal of biomedical materials research. Part A 110 (8) (2022)
James Forster Iii, Dipika Nandi, Ashish A Kulkarni
mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency. Biomaterials science 10 (19) (2022)
Dipika Nandi, Manisha Shivrayan, Jingjing Gao, Jithu Krishna, Ritam Das, Bin Liu, Sankaran Thayumanavan, Ashish A Kulkarni
Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation. ACS applied materials & interfaces 13 (38) (2021)
Anujan Ramesh, Anthony Brouillard, Ashish A Kulkarni
Supramolecular Nanotherapeutics for Macrophage Immunotherapy. ACS applied bio materials 4 (6) (2021)
Anujan Ramesh, Vaishali Malik, Hayat Anu Ranjani, Harriet Smith, Ashish A Kulkarni
Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor-loaded nanoparticle enhances anticancer efficacy. Drug delivery and translational research 11 (6) (2021)
Anthony Brouillard, Nilesh U Deshpande, Ashish A Kulkarni
Engineered Multifunctional Nano- and Biological Materials for Cancer Immunotherapy. Advanced healthcare materials 10 (6) (2021)
Anujan Ramesh, Sahana Kumar, Anthony Brouillard, Dipika Nandi, Ashish A Kulkarni
A Nitric Oxide (NO) Nanoreporter for Noninvasive Real-Time Imaging of Macrophage Immunotherapy. Advanced materials (Deerfield Beach, Fla.) 32 (24) (2020)
Anh Nguyen, Anujan Ramesh, Sahana Kumar, Dipika Nandi, Anthony Brouillard, Alexandria C Wells, Leonid A Pobezinsky, Barbara A Osborne, Ashish A Kulkarni
Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy. Science advances 6 (40) (2020)
Sahana Kumar, Anujan Ramesh, Ashish A Kulkarni
Targeting macrophages: a novel avenue for cancer drug discovery. Expert opinion on drug discovery 15 (5) (2020)
Anujan Ramesh, Siva Kumar Natarajan, Dipika Nandi, Ashish A Kulkarni
Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor. Cellular and molecular bioengineering 12 (5) (2019)
Anujan Ramesh, Sahana Kumar, Dipika Nandi, Ashish A Kulkarni
CSF1R- and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages. Advanced materials (Deerfield Beach, Fla.) 31 (51) (2019)
Ashish A Kulkarni, Vineethkrishna Chandrasekar, Siva Kumar Natarajan, Anujan Ramesh, Prithvi Pandey, Jayashree Nirgud, Harshangda Bhatnagar, Driti Ashok, Amrendra Kumar Ajay, Shiladitya Sengupta
A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer. Nature biomedical engineering 2 (8) (2018)

Ashish A Kulkarni.css-eqlu8i{font-size:small;padding-left:4px;} (Ashish Kulkarni)

Publication Activity (10 Years)

Top Topics

Top Venues

Ashish A Kulkarni (Ashish Kulkarni)